Novo
by PathAI, Inc.
510(k) K212361
Novo is a medical device (FDA Class II; FDA product code QKQ, Digital Pathology Image Viewing And Management Software) made by PathAI, Inc., cleared under FDA 510(k) K212361 on 11 Aug 2022, active as of 11 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK212361 | Date11 Aug 2022 | StatusActive |
Official records
- FDA 510(k) database K212361
From the FDA record
- Received by the FDA
- 30 Jul 2021
- FDA decision
- 11 Aug 2022 (Substantially Equivalent)
- FDA review time
- 377 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- QKQ
- Device class
- Class II
- Regulation
- 21 CFR Part 864.3700
- Advisory committee
- Pathology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code QKQ (Digital Pathology Image Viewing And Management Software).
- Sectra Digital Pathology Module by Sectra AB
- FullFocusTM Whole Slide Image Viewer 2.X by Paige.AI, Inc.
- Concentriq AP-Dx by Proscia, Inc.
- Viewer+ by Lumea, Inc.
- aetherSlide by aetherAI Co., Ltd.
- PathPresenter Clinical Viewer by PATHPRESENTER CORP
- FullFocus by Paige.AI, Inc.
- HALO AP Dx by Indica Labs
- MetaLite DX Digital Pathology Software by Jellox Biotech, Inc.
- Dynamyx Digital Pathology Software by Inspirata, Inc.